돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1167472생성일: 2026년 10월 26일

(5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one → (5R)-3-[3-fluoro-4-(4-methylimidazol-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one

https://huagongshe.com/reaction/1167472

반응식

참여 물질

역할이름HCID투입량
반응물(5R)-3-[3-fluoro-4-(3-hydroxyazetidin-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-oneHCID 497421—
반응물(5R)-3-(3-Fluoro-4-(4-methylimidazol-1-yl)phenyl)-5-hydroxymethyloxazolidin-2-oneHCID 21356561—
생성물(5R)-3-[3-fluoro-4-(4-methylimidazol-1-yl)phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-oneHCID 497413—

반응 단계

Using essentially the same procedure as for the intermediate of Example 65, but starting with 3-(3-fluoro-4-(4-methyl-imidazol-1-yl)phenyl)-5(R)-hydroxymethyloxazolidin-2-one (see Example 141; 81 mg, 0.29 mmol), and purifying by chromatography on a 5 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 2.5% MeOH in dichloromethane, gave the title compound (80 mg). MS (ESP): 359 (MH+) for C17H15FN4O4.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06617339B1
출처 데이터셋uspto-grants-2003_09
ORD IDord-676689885d374ceda4ff464daee93722
출처 메모uspto-grants-2003_09